Brief: Kuros Biosciences FY Revenues Up At CHF 2.6 Million

Kuros Biosciences AG

26/03/2020 06:09

March 26 (Reuters) - Kuros Biosciences AG  KURN.S :
    * FY REVENUES INCREASED TO CHF 2.6 MILLION
    * FY NET OPERATING COSTS DECREASED TO CHF 13.5 MILLION
    * STRONG FIRST TWO MONTHS OF 2020 IN TERMS OF REVENUES
    * DUE TO CODIV-19 EXPECTS SOME DELAYS IN OUR TIMELINES AS
ELECTIVE
SURGERY IS PUT BACK

Source text for Eikon:  ID:nTEN4w8j4a 
Further company coverage:  KURN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))